Search research articles
Contact Us
Filters
Showing results (271-280 of 363) with videos related to
Page
of 37
Sort By:
Cancer
|
August 4, 2022
A telehealth intervention for symptom management, distress, and adherence to adjuvant endocrine therapy: A randomized controlled trial
Jamie M Jacobs, Kathryn Post, Katina Massad, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 28, 2023
Local Recurrence After Breast-Conserving Therapy in Patients With Multiple Ipsilateral Breast Cancer: Results From ACOSOG Z11102 (Alliance)
Judy C Boughey, Kari M Rosenkranz, Karla V Ballman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 6, 2022
Circulating Tumor DNA and Late Recurrence in High-Risk Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer
Marla Lipsyc-Sharf, Elza C de Bruin, Katheryn Santos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 21, 2025
Association of tumor-infiltrating lymphocyte subtypes with clinical characteristics and prognosis in young women with hormone receptor-positive breast cancer
Megan E Tesch, Yue Zheng, Yaileen D Guzman-Arocho, et al.
Blood Advances
|
September 21, 2022
Patient perspectives on testing for clonal hematopoiesis of indeterminate potential
Tal Sella, Geoffrey G Fell, Peter G Miller, et al.
Annals of Surgery
|
December 30, 2020
Surgical Treatment After Neoadjuvant Systemic Therapy in Young Women With Breast Cancer: Results From a Prospective Cohort Study
Hee Jeong Kim, Laura Dominici, Shoshana M Rosenberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 2, 2019
Mortality After Breast Cancer Among Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study
Chaya S Moskowitz, Joanne F Chou, Joseph P Neglia, et al.
Annals of Surgical Oncology
|
July 27, 2025
Patient-reported Outcomes After Routine Treatment of In Situ/Atypical Lesions: The PORTAL Study
Shoshana M Rosenberg, Christel Rushing, Kristin L Schreiber, et al.
Nature Communications
|
March 20, 2024
Exemestane plus everolimus and palbociclib in metastatic breast cancer: clinical response and genomic/transcriptomic determinants of resistance in a phase I/II trial
Jorge Gómez Tejeda Zañudo, Romualdo Barroso-Sousa, Esha Jain, et al.
Journal of Geriatric Oncology
|
June 9, 2024
Palbociclib in adults aged 70 years and older with advanced breast cancer: A phase 2 multicenter trial (Alliance A171601)
Mina S Sedrak, Minji K Lee, Jingran Ji, et al.
Page
of 37
Search research articles
Search
Showing results (271-280 of 363) with videos related to
Sort By:
Page
of 37
Cancer
|
August 4, 2022
A telehealth intervention for symptom management, distress, and adherence to adjuvant endocrine therapy: A randomized controlled trial
Jamie M Jacobs, Kathryn Post, Katina Massad, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 28, 2023
Local Recurrence After Breast-Conserving Therapy in Patients With Multiple Ipsilateral Breast Cancer: Results From ACOSOG Z11102 (Alliance)
Judy C Boughey, Kari M Rosenkranz, Karla V Ballman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 6, 2022
Circulating Tumor DNA and Late Recurrence in High-Risk Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer
Marla Lipsyc-Sharf, Elza C de Bruin, Katheryn Santos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 21, 2025
Association of tumor-infiltrating lymphocyte subtypes with clinical characteristics and prognosis in young women with hormone receptor-positive breast cancer
Megan E Tesch, Yue Zheng, Yaileen D Guzman-Arocho, et al.
Blood Advances
|
September 21, 2022
Patient perspectives on testing for clonal hematopoiesis of indeterminate potential
Tal Sella, Geoffrey G Fell, Peter G Miller, et al.
Annals of Surgery
|
December 30, 2020
Surgical Treatment After Neoadjuvant Systemic Therapy in Young Women With Breast Cancer: Results From a Prospective Cohort Study
Hee Jeong Kim, Laura Dominici, Shoshana M Rosenberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 2, 2019
Mortality After Breast Cancer Among Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study
Chaya S Moskowitz, Joanne F Chou, Joseph P Neglia, et al.
Annals of Surgical Oncology
|
July 27, 2025
Patient-reported Outcomes After Routine Treatment of In Situ/Atypical Lesions: The PORTAL Study
Shoshana M Rosenberg, Christel Rushing, Kristin L Schreiber, et al.
Nature Communications
|
March 20, 2024
Exemestane plus everolimus and palbociclib in metastatic breast cancer: clinical response and genomic/transcriptomic determinants of resistance in a phase I/II trial
Jorge Gómez Tejeda Zañudo, Romualdo Barroso-Sousa, Esha Jain, et al.
Journal of Geriatric Oncology
|
June 9, 2024
Palbociclib in adults aged 70 years and older with advanced breast cancer: A phase 2 multicenter trial (Alliance A171601)
Mina S Sedrak, Minji K Lee, Jingran Ji, et al.
Page
of 37